K K Venkat
Overview
Explore the profile of K K Venkat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
148
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liquete E, Williamson S, Janakiraman N, Venkat K
Indian J Nephrol
. 2017 Dec;
27(6):468-471.
PMID: 29217887
We report the development of minimal change disease superimposed on preexisting chronic kidney disease secondary to chronic calcineurin inhibitor nephrotoxicity in a hematopoietic stem cell transplantation (HSCT) recipient and review...
2.
Prashar R, Venkat K
Adv Chronic Kidney Dis
. 2016 Oct;
23(5):295-300.
PMID: 27742383
Kidney transplantation is well established as the best treatment option for end-stage kidney disease. It confers not only a better quality of life but also a significant survival advantage compared...
3.
Haider M, Yessayan L, Venkat K, Goggins M, Patel A, Karthikeyan V
Transplant Proc
. 2015 Mar;
47(2):379-83.
PMID: 25769577
Unlabelled: Contrast-induced nephropathy (CIN) is responsible for one-third of acute kidney injuries (AKI) in the hospital setting. The incidence of CIN varies from 3% to 30%, depending on the preexisting...
4.
5.
Hatoum H, Patel A, Venkat K
ISRN Nephrol
. 2014 Jun;
2014:292305.
PMID: 24967241
Delayed graft function (DGF) of kidney transplants increases risk of rejection. We aimed to assess the utility of weekly biopsies during DGF in the setting of currently used immunosuppression and...
6.
Venkat K, Eshelman A
Transplant Rev (Orlando)
. 2014 May;
28(3):134-9.
PMID: 24849414
Living donor kidney transplantation which involves performing a major surgical procedure on a healthy person solely to benefit another person has always involved dealing with difficult ethical issues. Beneficence, non-maleficence,...
7.
Parasuraman R, Venkat K, Abouljoud M, Samarapungavan D, Rocher L, Koffron A
Transplant Proc
. 2013 Nov;
45(9):3269-72.
PMID: 24182798
Background: Successful kidney transplantation despite positive crossmatch (+CXM) before transplantation is well recognized in combined liver-kidney transplant (CLKT) recipients. This is probably due to immunologic protection of the renal allograft...
8.
Parasuraman R, Abouljoud M, Jacobsen G, Reddy G, Koffron A, Venkat K
Transplantation
. 2011 Apr;
91(1):94-9.
PMID: 21452413
Background: Advances in kidney transplantation have significantly improved early outcomes but failed to improve long-term graft survival. Despite many causes, the contribution of infection to death-censored graft failure (DCGF) is...
9.
Venkat D, Venkat K
South Med J
. 2010 Jun;
103(7):654-61.
PMID: 20531067
Acute kidney injury (AKI) secondary to hepatorenal syndrome (HRS) is an ominous complication of end-stage liver disease (ESLD). In HRS, splanchnic and peripheral vasodilatation with reduction in effective arterial volume...
10.
Parasuraman R, Samarapungavan D, Venkat K
Transplant Rev (Orlando)
. 2010 Mar;
24(2):43-51.
PMID: 20303455
Renal transplantation is now considered the treatment of choice for patients with end-stage renal disease. In transplant recipients, infection and rejection are entwined and are unavoidable tribulations unless clinical tolerance...